サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1405050

心血管デバイスの市場規模、シェア、動向分析レポート：製品別、地域別、セグメント予測、2023年～2030年

Cardiovascular Devices Market Size, Share & Trends Analysis Report By Product (Diagnostic & Monitoring (ECG, Holter), Surgical Devices (Pacemakers, Stents)), By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 95 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
心血管デバイスの市場規模、シェア、動向分析レポート：製品別、地域別、セグメント予測、2023年～2030年
出版日: 2023年11月28日
発行: Grand View Research
ページ情報: 英文 95 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

心血管デバイス市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の心血管デバイス市場規模は2030年までに835億6,000万米ドルに達し、CAGRは7.1％を記録すると予測されています。

高齢者人口の増加、不健康な食生活と相まって座りがちな生活スタイルが心血管疾患の蔓延に拍車をかけています。心血管疾患を患う患者の絶え間ない増加が、予測期間中の市場成長を促進すると予測されています。

政府は病院に罰則を課すことで、病院内感染（HAI）の蔓延を減らすため、病院の再入院を制限しようとしています。その結果、在宅ヘルスケア、遠隔患者モニタリング、長期介護サービスの採用が急速に増加しています。このため、病院、在宅患者、長期ケアセンターからの心血管デバイスに対する需要が増加しています。

加えて、保険償還の適用など政府の好意的な政策がこれらの機器の採用を後押ししています。このように、対象となる患者人口の増加、在宅ヘルスケア受け入れの増加、有利な政府政策は、世界の心血管デバイス市場の成長を促進する主な要因の一部です。

一方、デバイスのコストが高く、規制当局の承認手続きが厳しいことが、市場の成長を阻む主な課題となっています。また、先進的なデバイスを使用して外科手術を行う熟練した専門家の不足が、新しいデバイスの採用を妨げています。

心血管デバイス市場のレポートハイライト

  • 低侵襲手術器具の入手可能性と手術費用の高さが相まって、手術器具の収益シェアが高くなっています。その結果、2022年の市場全体では外科用機器部門が優位を占める。
  • 診断・モニタリング機器分野は、予測期間中に7.6%と最も速い成長率で成長すると予測されています。疾病の早期診断を促進する政府の取り組み、在宅ヘルスケアサービスや長期ケアセンターの導入増加が、主に診断・モニタリング分野の成長にプラスの影響を与えています。
  • 北米は2022年の世界市場で35.0%のシェアを占めました。対象人口の多さ、償還範囲、高度な治療への高い採用率が、北米の心血管デバイス市場の成長を促進する要因となっています。
  • さらに、有利な政府政策と明確に定義された規制枠組みの存在は、北米の市場成長を増大させる要因の一部です。
  • アジア太平洋地域は予測期間中に大きな成長を記録すると予測されています。同地域の成長は主に、アジア太平洋地域で心疾患を患いやすい高齢者人口の増加が予想されることと、医療ツーリズムが活況を呈していることに起因しています。
  • さらに、インドや中国など新興国市場が急速に発展している国の存在は、アジア太平洋市場にプラスの成長をもたらすと予想されます。医療インフラを改善するための政府の取り組み、医療費の増加、高度な医療施設に対する需要の増加は、インドと中国の市場を急成長へと押し上げると予想される要因の一部です。
  • 世界市場に貢献している主要企業は、Medtronic plc、Becton Dickinsonなどです。主要企業間の競合要因は、製造能力、強力な流通網、価格戦略、製品革新などであるが、これらに限定されるものではないです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 心血管デバイス市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 普及と成長の見通しマッピング
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 心血管デバイス市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 心血管デバイス：製品の推定・動向分析

  • 心血管デバイス市場：重要なポイント
  • 心血管デバイス市場：動向と市場シェア分析、2022年および2030年
  • 診断および監視デバイス
  • 外科手術用器具

第5章 心血管デバイス市場：地域の推定・動向分析

  • 地域別の見通し
  • 地域別の心臓血管機器市場：主要なマーケットプレース要点
  • 北米
    • 市場推計・予測、2018～2030年
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • ノルウェー
    • デンマーク
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • クウェート

第6章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 市場参入企業の分類
    • Abbott
    • GE HealthCare
    • Edwards Lifesciences Corporation
    • W. L. Gore & Associates, Inc.
    • Siemens Healthcare GmbH
    • BIOTRONIK SE & Co. KG
    • Canon Medical Systems Asia Pte. Ltd.
    • B. Braun SE
    • LivaNova PLC
    • Cardinal Health
    • Medtronic
    • Boston Scientific Corporation
図表

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America cardiovascular devices market, by product, 2018 - 2030 (USD Million)
  • Table 3 North America cardiovascular devices market, by region, 2018 - 2030 (USD Million)
  • Table 4 U.S. cardiovascular devices market, by product, 2018 - 2030 (USD Million)
  • Table 5 Canada cardiovascular devices market, by product, 2018 - 2030 (USD Million)
  • Table 6 Europe cardiovascular devices market, by product, 2018 - 2030 (USD Million)
  • Table 7 Europe cardiovascular devices market, by region, 2018 - 2030 (USD Million)
  • Table 8 Germany cardiovascular devices market, by product, 2018 - 2030 (USD Million)
  • Table 9 UK cardiovascular devices market, by product, 2018 - 2030 (USD Million)
  • Table 10 France cardiovascular devices market, by product, 2018 - 2030 (USD Million)
  • Table 11 Italy cardiovascular devices market, by product, 2018 - 2030 (USD Million)
  • Table 12 Spain cardiovascular devices market, by product, 2018 - 2030 (USD Million)
  • Table 13 Sweden cardiovascular devices market, by product, 2018 - 2030 (USD Million)
  • Table 14 Norway cardiovascular devices market, by product, 2018 - 2030 (USD Million)
  • Table 15 Denmark cardiovascular devices market, by product, 2018 - 2030 (USD Million)
  • Table 16 Asia Pacific cardiovascular devices market, by product, 2018 - 2030 (USD Million)
  • Table 17 Asia Pacific cardiovascular devices market, by region, 2018 - 2030 (USD Million)
  • Table 18 China cardiovascular devices market, by product, 2018 - 2030 (USD Million)
  • Table 19 Japan cardiovascular devices market, by product, 2018 - 2030 (USD Million)
  • Table 20 India cardiovascular devices market, by product, 2018 - 2030 (USD Million)
  • Table 21 Australia cardiovascular devices market, by product, 2018 - 2030 (USD Million)
  • Table 22 Thailand cardiovascular devices market, by product, 2018 - 2030 (USD Million)
  • Table 23 South Korea cardiovascular devices market, by product, 2018 - 2030 (USD Million)
  • Table 24 Latin America cardiovascular devices market, by product, 2018 - 2030 (USD Million)
  • Table 25 Latin America cardiovascular devices market, by region, 2018 - 2030 (USD Million)
  • Table 26 Brazil cardiovascular devices market, by product, 2018 - 2030 (USD Million)
  • Table 27 Mexico cardiovascular devices market, by product, 2018 - 2030 (USD Million)
  • Table 28 Argentina cardiovascular devices market, by product, 2018 - 2030 (USD Million)
  • Table 29 Middle East and Africa cardiovascular devices market, by product, 2018 - 2030 (USD Million)
  • Table 30 Middle East and Africa cardiovascular devices market, by region, 2018 - 2030 (USD Million)
  • Table 31 South Africa cardiovascular devices market, by product, 2018 - 2030 (USD Million)
  • Table 32 Saudi Arabia cardiovascular devices market, by product, 2018 - 2030 (USD Million)
  • Table 33 UAE cardiovascular devices market, by product, 2018 - 2030 (USD Million)
  • Table 34 Kuwait cardiovascular devices market, by product, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Cardiovascular devices market: Market outlook
  • Fig. 9 Cardiovascular devices market: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Cardiovascular devices market driver impact
  • Fig. 15 Cardiovascular devices market restraint impact
  • Fig. 16 Cardiovascular devices market strategic initiatives analysis
  • Fig. 17 Cardiovascular devices market: Product movement analysis
  • Fig. 18 Cardiovascular devices market: Product outlook and key takeaways
  • Fig. 19 Diagnostic and monitoring devices
  • Fig. 20 ECG market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Holter monitors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Event monitors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Implantable loop recorders market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Echocardiogram market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Pet scan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 MRI market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Cardiac CT market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Doppler fetal monitors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Cardiac diagnostic catheters market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Surgical devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Pacemakers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Catheters and accessories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Guidewires market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Cannulae market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Electrosurgical procedures market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Valves market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Occlusion devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Global Cardiovascular devices market: Regional movement analysis
  • Fig. 40 Global cardiovascular devices market: Regional outlook and key takeaways
  • Fig. 41 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
目次
Product Code: 978-1-68038-992-0

Cardiovascular Devices Market Growth & Trends:

The global cardiovascular devices market size is anticipated to reach USD 83.56 billion by 2030, registering a CAGR of 7.1%, according to a new report by Grand View Research, Inc. Increasing geriatric population, sedentary life style coupled with unhealthy dietary habits is spurring the prevalence of cardiovascular diseases. Constant rise in the patients suffering from cardiovascular diseases and is expected to drive market growth during the forecast period.

Governments are trying to limit hospital readmissions to reduce the prevalence of hospital acquired infections (HAIs) by imposing penalties on hospitals. As a result, adoption of home healthcare, remote patient monitoring, and long term care services is rapidly increasing. Thus, demand for cardiovascular devices is increasing from hospitals, patients based in home settings, and long term care centers.

In addition, favorable government policies such as reimbursement coverage are fueling adoption of these devices. Thus, increasing target patient population, rising acceptance of home healthcare, and favorable government policies are some of the major factors driving the growth of the global cardiovascular devices market.

On the other hand, high device cost and stringent regulatory approval procedure are some of the prime factors challenging the growth of the market. In addition, lack of skilled professionals to perform surgical procedures using advanced devices is impeding the adoption of new devices.

Cardiovascular Devices Market Report Highlights:

  • Availability of minimally invasive surgical devices coupled with high surgical cost is resulting in higher revenue share of surgical devices. As a result, surgical devices segment dominated the overall market in 2022
  • Diagnostics and monitoring device segment is anticipated to grow at the fastest growth rate of 7.6% during the forecast period. Government initiatives to promote early diagnosis of the diseases, increasing adoption of home healthcare services and long term care centers is primarily affecting the growth of diagnostic and monitoring segment positively.
  • North America dominated with market share of 35.0% of the global market in 2022. Presence of large pool of target population, reimbursement coverage and high adoption rate for advanced treatments are some of the factors driving the growth of the cardiovascular devices market in North America.
  • Furthermore, favorable government policies and presence of well-defined regulatory framework are some of the factors augmenting the market growth in North America.
  • Asia Pacific is anticipated to register significant growth during the forecast period. Growth of the region would primarily attribute to anticipated rise in geriatric population prone to cardiac diseases and booming medical tourism in Asia Pacific.
  • Moreover, presence of rapidly developing countries such as India and China are expected to render positive growth to the Asia Pacific market. Government initiatives to improve healthcare infrastructure, increasing healthcare expenditure and increasing demand for advanced healthcare facilities are some of the factors anticipated to push the market in India and China towards swift growth.
  • Major players contributing to the global market include, Medtronic plc, Becton Dickinson Competition among the key players would depend upon several factors included but not limited to manufacturing capacity, strong distribution network, pricing strategy and product innovation

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Cardiovascular Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Cardiovascular Devices Market Analysis Tools
    • 3.4.1. Industry analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Cardiovascular Devices: Product Estimates & Trend Analysis

  • 4.1. Cardiovascular Devices Market: Key Takeaways
  • 4.2. Cardiovascular Devices Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Diagnostic and Monitoring Devices
    • 4.3.1. Diagnostic and monitoring devices estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.3.1.1. ECG
      • 4.3.1.1.1. ECG market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.3.1.2. Holter monitors
      • 4.3.1.2.1. Holter monitors market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.3.1.3. Event monitors
      • 4.3.1.3.1. Event monitors market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.3.1.4. Implantable loop recorders
      • 4.3.1.4.1. Implantable loop recorders market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.3.1.5. Echocardiogram
      • 4.3.1.5.1. Echocardiogram estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.3.1.6. Pet scan
      • 4.3.1.6.1. Pet scan market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.3.1.7. MRI
      • 4.3.1.7.1. MRI market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.3.1.8. Cardiac CT
      • 4.3.1.8.1. Cardiac CT market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.3.1.9. Doppler fetal monitors
      • 4.3.1.9.1. Doppler fetal monitors market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.3.1.10. Cardiac diagnostic catheters
      • 4.3.1.10.1. Cardiac diagnostic catheters market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Surgical Devices
    • 4.4.1. Surgical devices market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.1. Pacemakers
      • 4.4.1.1.1. Pacemakers market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.2. Stents
      • 4.4.1.2.1. Stents market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.3. Catheters and accessories
      • 4.4.1.3.1. Catheters and accessories market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.4. Guidewires
      • 4.4.1.4.1. Guidewires market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.5. Cannulae
      • 4.4.1.5.1. Cannulae market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.6. Electrosurgical procedures
      • 4.4.1.6.1. Electrosurgical procedures market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.7. Valves
      • 4.4.1.7.1. Valves market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.8. Occlusion devices
      • 4.4.1.8.1. Occlusion devices market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Cardiovascular Devices Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Outlook
  • 5.2. Cardiovascular Devices Market by Region: Key Marketplace Takeaway
  • 5.3. North America
    • 5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.2. U.S.
      • 5.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.3. Canada
      • 5.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.4. Europe
    • 5.4.1. UK
      • 5.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.2. Germany
      • 5.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.3. France
      • 5.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.4. Italy
      • 5.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.5. Spain
      • 5.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.6. Sweden
      • 5.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.7. Norway
      • 5.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.8. Denmark
      • 5.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Japan
      • 5.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.2. China
      • 5.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.3. India
      • 5.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.4. Australia
      • 5.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.5. Thailand
      • 5.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.6. South Korea
      • 5.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.6. Latin America
    • 5.6.1. Brazil
      • 5.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.2. Mexico
      • 5.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.3. Argentina
      • 5.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.7. MEA
    • 5.7.1. Saudi Arabia
      • 5.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.2. South Africa
      • 5.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.3. UAE
      • 5.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.4. Kuwait
      • 5.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Market Participant Categorization
    • 6.2.1. Abbott
      • 6.2.1.1. Company overview
      • 6.2.1.2. Financial performance
      • 6.2.1.3. Product benchmarking
      • 6.2.1.4. Strategic initiatives
    • 6.2.2. GE HealthCare
      • 6.2.2.1. Company overview
      • 6.2.2.2. Financial performance
      • 6.2.2.3. Product benchmarking
      • 6.2.2.4. Strategic initiatives
    • 6.2.3. Edwards Lifesciences Corporation
      • 6.2.3.1. Company overview
      • 6.2.3.2. Financial performance
      • 6.2.3.3. Product benchmarking
      • 6.2.3.4. Strategic initiatives
    • 6.2.4. W. L. Gore & Associates, Inc.
      • 6.2.4.1. Company overview
      • 6.2.4.2. Financial performance
      • 6.2.4.3. Product benchmarking
      • 6.2.4.4. Strategic initiatives
    • 6.2.5. Siemens Healthcare GmbH
      • 6.2.5.1. Company overview
      • 6.2.5.2. Financial performance
      • 6.2.5.3. Product benchmarking
      • 6.2.5.4. Strategic initiatives
    • 6.2.6. BIOTRONIK SE & Co. KG
      • 6.2.6.1. Company overview
      • 6.2.6.2. Financial performance
      • 6.2.6.3. Product benchmarking
      • 6.2.6.4. Strategic initiatives
    • 6.2.7. Canon Medical Systems Asia Pte. Ltd.
      • 6.2.7.1. Company overview
      • 6.2.7.2. Financial performance
      • 6.2.7.3. Product benchmarking
      • 6.2.7.4. Strategic initiatives
    • 6.2.8. B. Braun SE
      • 6.2.8.1. Company overview
      • 6.2.8.2. Financial performance
      • 6.2.8.3. Product benchmarking
      • 6.2.8.4. Strategic initiatives
    • 6.2.9. LivaNova PLC
      • 6.2.9.1. Company overview
      • 6.2.9.2. Financial performance
      • 6.2.9.3. Product benchmarking
      • 6.2.9.4. Strategic initiatives
    • 6.2.10. Cardinal Health
      • 6.2.10.1. Company overview
      • 6.2.10.2. Financial performance
      • 6.2.10.3. Product benchmarking
      • 6.2.10.4. Strategic initiatives
    • 6.2.11. Medtronic
      • 6.2.11.1. Company overview
      • 6.2.11.2. Financial performance
      • 6.2.11.3. Product benchmarking
      • 6.2.11.4. Strategic initiatives
    • 6.2.12. Boston Scientific Corporation
      • 6.2.12.1. Company overview
      • 6.2.12.2. Financial performance
      • 6.2.12.3. Product benchmarking
      • 6.2.12.4. Strategic initiatives